BioMarin Pharmaceutical develops and markets enzyme-replacement therapies and other treatments for rare genetic diseases.
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| Ancora | 38 | Trimmed -24% | 702 | $41,720 | 0.0% |
| Paul Tudor Jones / Tudor | 57 | Trimmed -20% | 162,223 | $9,640,913 | 0.0% |
| Trade date | Who | Type | Amount | |
|---|---|---|---|---|
| 2026-07-01 | Trump, Donald J President | BUY | $1,001 - $15,000 | PTR |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-07-02.